Mark Lebwohl, MD, Shares Updates on Recent Clinical Breakthroughs and Agents in the Pipeline
February 17th 2023“A lot of our colleagues are just getting used to the new biologics for atopic dermatitis like tralokinumab and dupilumab, which have really been breakthroughs in the treatment of atopic dermatitis,” Lebwohl, one of the co-founders of the Fall and Winter Clinical meetings, says.